2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)

BACKGROUND: NP is a frequent healthcare-acquired infection associated with high mortality; rising resistance rates among causative Gram-negative pathogens require new treatment options. In the randomized, controlled, double-blind, phase 3 ASPECT-NP trial, C/T (at double the initially approved dose)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wunderink, Richard G, Bruno, Christopher, Martin-Loeches, Ignacio, Kollef, Marin, Timsit, Jean-Francois, Yu, Brian, Huntington, Jennifer A, Li, Linping, Jensen, Erin, Wolf, Dominik, Butterton, Joan R, Rhee, Elizabeth G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810350/
http://dx.doi.org/10.1093/ofid/ofz360.1904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810350/
http://dx.doi.org/10.1093/ofid/ofz360.1904

Ejemplares similares